Specialty Medicines. Strategic Partnerships. Better Access.
Product list

Varifarma Products

58 products with active ingredients, strengths, pack sizes and therapeutic uses. Search or filter the list below.

Showing 58 of 58 products

Enquire
1Anastrozol VarifarmaOralAnastrozole1 mgTablets; typically 28/30 tabletsBreast cancer; hormone-receptor-positive diseaseEnquire
2BozatinixOralCabozantinib20 mg, 40 mg, 60 mgTablets; pack size varies by marketRenal cell carcinoma; hepatocellular carcinoma; differentiated thyroid cancerEnquire
3CabazilInjectableCabazitaxel60 mg/1.5 mL1 vial (with solvent/diluent depending on presentation)Metastatic castration-resistant prostate cancerEnquire
4CanitibOralNeratinib40 mg180 tablets commonly used for a 30-day supplyExtended adjuvant treatment of HER2-positive early breast cancerEnquire
5Capecitabina VarifarmaOralCapecitabine150 mg, 500 mgTablets; commonly 120 tablets for 500 mg presentationColorectal, breast and gastric/GE-junction cancersEnquire
6Carboplatino VarifarmaInjectableCarboplatin150 mg/15 mL, 450 mg/45 mL1 vialOvarian, lung, head & neck and other solid tumorsEnquire
7CiprofarmaOralCyproterone50 mg30 tablets commonlyAndrogen-dependent prostate cancer; androgen suppressionEnquire
8CPT 11InjectableIrinotecan100 mg/5 mL1 vialColorectal cancer; other solid tumors in combination regimensEnquire
9Dacarbazina VarifarmaInjectableDacarbazine200 mg1 vialMetastatic melanoma; Hodgkin lymphoma and other malignanciesEnquire
10GefitOralGefitinib250 mg30 tablets commonlyEGFR-mutated non-small-cell lung cancerEnquire
11IxafnibOralAxitinib1 mg, 5 mg56 tablets commonlyAdvanced renal cell carcinomaEnquire
12KipanibOralPazopanib200 mg, 400 mg30 tablets commonlyRenal cell carcinoma; advanced soft-tissue sarcomaEnquire
13LenvatibOralLenvatinib4 mg, 10 mg30 capsules commonlyDifferentiated thyroid cancer; renal cell carcinoma; hepatocellular carcinoma; endometrial cancer in combinationsEnquire
14Letrozol VarifarmaOralLetrozole2.5 mg30 tablets commonlyHormone-receptor-positive breast cancerEnquire
15MaximitomInjectableMitomycin C10 mg, 20 mg1 vialBladder cancer; GI and other solid tumors; ophthalmic/other specialist usesEnquire
16Paclitaxel VarifarmaInjectablePaclitaxel30 mg/5 mL, 100 mg/16.7 mL, 260 mg/43.4 mL1 vialOvarian, breast, non-small-cell lung and other cancersEnquire
17RoteronaOralAbiraterone250 mg, 500 mgTablets; pack varies by marketMetastatic prostate cancerEnquire
18RupovarOralRucaparib200 mg, 250 mg, 300 mg60 tablets commonlyBRCA-mutated advanced ovarian/fallopian tube/primary peritoneal cancer; prostate cancer in selected settingsEnquire
19SuprolOralTrifluridine/Tipiracil15/6.14 mg, 20/8.19 mg20 tablets commonlyMetastatic colorectal cancer; metastatic gastric/GE-junction cancerEnquire
20Tamoxifeno VarifarmaOralTamoxifen10 mg, 20 mg30 tablets commonlyHormone-receptor-positive breast cancer; prevention in selected high-risk patientsEnquire
21UltraciclibOralPalbociclib75 mg, 100 mg, 125 mg21 capsules/tablets per cycle pack commonlyHR-positive/HER2-negative advanced or metastatic breast cancerEnquire
22UnitiobOralSunitinib12.5 mg, 25 mg, 37.5 mg, 50 mg28 capsules/tablets commonlyRenal cell carcinoma; GIST; pancreatic neuroendocrine tumorsEnquire
23VarigestrolOralMegestrol40 mg, 160 mgTablets; pack variesAdvanced endometrial or breast cancer; appetite/cachexia management in selected settingsEnquire
24VaxemesOralExemestane25 mg30 tablets commonlyHormone-receptor-positive breast cancerEnquire
25VarizolomidaOralTemozolomide5 mg, 20 mg, 100 mg, 140 mg, 180 mg, 250 mg5 or 20 capsules/tablets depending on strength/marketGlioblastoma and anaplastic astrocytomaEnquire
26BendavarInjectableBendamustine100 mg1 vialChronic lymphocytic leukemia; indolent B-cell non-Hodgkin lymphomaEnquire
27BinapOralIbrutinib140 mg, 280 mg, 420 mg, 560 mg28 capsules/tablets commonlyCLL/SLL, mantle cell lymphoma, Waldenström macroglobulinemia and other B-cell malignanciesEnquire
28CelazaInjectableAzacitidine100 mg1 vialMyelodysplastic syndromes; acute myeloid leukemiaEnquire
29CistadineInjectableClofarabine1 mg/mL (20 mL vial = 20 mg)1 vialRelapsed/refractory acute lymphoblastic leukemia in pediatric patientsEnquire
30DeygluxOralEliglustat84 mg60 capsules commonlyGaucher disease type 1Enquire
31DricaleuInjectableCladribine10 mg/mL1 vialHairy cell leukemia; selected hematologic malignanciesEnquire
32FostaxOralFostamatinib100 mg, 150 mg60 tablets commonlyChronic immune thrombocytopenia in adults with insufficient response to prior treatmentEnquire
33Hidroxiurea VarifarmaOralHydroxyurea500 mg100 capsules/tablets commonlyMyeloproliferative disorders; sickle cell diseaseEnquire
34Idarubicina VarifarmaInjectableIdarubicin5 mg, 10 mg1 vialAcute myeloid leukemia; selected acute leukemiasEnquire
35LeunibOralDasatinib20 mg, 50 mg, 70 mg, 80 mg, 100 mg, 140 mg30 tablets commonlyPhiladelphia chromosome-positive CML; Ph+ ALLEnquire
36LinotaxOralNilotinib150 mg, 200 mg112 capsules commonly (4-week supply)Philadelphia chromosome-positive CMLEnquire
37MaxidaunoInjectableDaunorubicin20 mg1 vialAcute myeloid/lymphoblastic leukemia; other hematologic malignanciesEnquire
38NIBCLUSOralPonatinib15 mg, 30 mg, 45 mg30 tablets commonlyPh+ CML and Ph+ ALL, including T315I mutationEnquire
39VarimerOralMercaptopurine50 mg25/50/100 tablets depending on marketAcute lymphoblastic leukemia; maintenance therapyEnquire
40VarimesnaInjectable & oralMesna100 mg/mL injection; 400 mg/1000 mg tablets in some marketsInjection vial/ampoule; oral pack variesPrevention of urotoxicity from ifosfamide and selected oxazaphosphorinesEnquire
41VaritrinoxInjectableArsenic trioxide1 mg/mL (10 mg/10 mL)1 vialAcute promyelocytic leukemiaEnquire
42VaridronicoInjectableZoledronic acid4 mg/5 mL1 vialCancer-related hypercalcemia; prevention/treatment of skeletal complications from bone metastasesEnquire
43Busulfan VarifarmaInjectableBusulfan6 mg/mL10 mL vialConditioning before hematopoietic stem-cell transplantationEnquire
44CelixaforInjectablePlerixafor20 mg/mL (24 mg/1.2 mL)1 vialStem-cell mobilization for autologous transplantationEnquire
45PhelinumInjectableMelphalan50 mg1 vialMultiple myeloma; conditioning for hematopoietic stem-cell transplantationEnquire
46TepadinaInjectableThiotepa15 mg1 vialConditioning for hematopoietic stem-cell transplantation; selected cancersEnquire
47Tepadina 400 mgInjectableThiotepa400 mg1 vialConditioning for hematopoietic stem-cell transplantation; selected cancersEnquire
48Posaconazol VarifarmaInjectable & oralPosaconazole40 mg/mL oral suspension; 100 mg gastro-resistant tablet; 300 mg injectionPack varies by formulationAntifungal prophylaxis/treatment in high-risk immunocompromised patientsEnquire
49AnfonaxInjectableLiposomal Amphotericin B50 mg/vial1 vialInvasive fungal infections; visceral leishmaniasisEnquire
50BocipalOralRelugolix40 mg30 tablets commonlyAdvanced prostate cancer; androgen-deprivation therapyEnquire
51MacynOralMacitentan10 mg30 tablets commonlyPulmonary arterial hypertensionEnquire
52RipulatOralRiociguat0.5 mg, 1 mg, 1.5 mg, 2 mg, 2.5 mg42 tablets commonly (titration pack)Pulmonary arterial hypertension; chronic thromboembolic pulmonary hypertensionEnquire
53SustengoOralTadalafil20 mg60 tablets commonly; market dependentPulmonary arterial hypertension; benign prostatic hyperplasia/erectile dysfunction depending on product/indicationEnquire
54HipularInjectableTreprostinil1 mg/mL, 2.5 mg/mL, 5 mg/mL, 10 mg/mLVial/cartridge; pack variesPulmonary arterial hypertensionEnquire
55VadroxOralRoxadustat20 mg, 50 mg, 70 mg, 100 mg, 150 mgTablets; pack varies by marketAnemia associated with chronic kidney diseaseEnquire
56JanvaxOralTofacitinib5 mg, 10 mg, 11 mg extended-release56 tablets commonlyRheumatoid arthritis; psoriatic arthritis; ulcerative colitisEnquire
57FunomidOralTeriflunomide7 mg, 14 mg28 tablets commonlyRelapsing forms of multiple sclerosisEnquire
58EmulimodOralFingolimod0.5 mg28 capsules commonlyRelapsing forms of multiple sclerosisEnquire

This list is provided for healthcare professionals and institutional buyers for information only. Strengths, pack sizes and indications are indicative and may vary by market. Availability in Pakistan is subject to DRAP registration, licensing and supply arrangements — please contact us to confirm.

Enquire about a product

Send us the product, strength and quantity you need and we will confirm availability and supply options.